RISPREE Trademark

Trademark Overview


On Thursday, November 29, 2012, a trademark application was filed for RISPREE with the United States Patent and Trademark Office. The USPTO has given the RISPREE trademark a serial number of 85790418. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 27, 2014. This trademark is owned by Glaxo Group Limited. The RISPREE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
rispree

General Information


Serial Number85790418
Word MarkRISPREE
Filing DateThursday, November 29, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 27, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 7, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, January 27, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 27, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 25, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 7, 2013ASSIGNED TO EXAMINER
Friday, December 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 3, 2012NEW APPLICATION ENTERED IN TRAM